75P-11825-54125
2 vaccinations
1 coded response
2 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 462 / IN
- Registered
- 2021-12-20
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-05-27
Dose 1 — Pfizer-BioNTech
-
2021-12-11
Dose 2 — Pfizer-BioNTech
-
2021-12-20
Registered in v-safe
- 2021-12-20
-
2022-01-03
Survey response — day 21, dose 2MedDRA: Nasal congestion, Respiratory tract congestion — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Stuffy nose and congestionMedDRA releases: 2024-11 · check-in free text available
-
2022-01-03
Report sent to call center — day 21, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-01-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-27 | Pfizer-BioNTech | No |
| 2 | 2021-12-11 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-01-03 | Unsuccessful |
Free text
Release 10 — day 21, dose 2
Symptoms: Stuffy nose and congestion
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasal congestion | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release